Form 4/A for TGEN TECOGEN INC.
Accepted 2025-07-14 00:00:00 ET · period of report 2025-06-03 · accession 0001537435-25-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2025-07-14 | 2025-06-16 | TGEN | PANORA ROBERT A | COO, Pres | M - OptEx | $0.9357 | +95.2K | 108.2K | +732% | +$89.1K |
| DMA | 2025-07-14 | 2025-06-03+ | TGEN | PANORA ROBERT A | COO, Pres | S - Sale+OE | $5.36 | -102.7K | 62.5K | -62% | -$550.8K |
| DMA | 2025-07-14 | 2025-06-16 | TGEN | PANORA ROBERT A | COO, Pres | M - OptEx | $0.9357 | -95.2K | 0 | -100% | -$89.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-16 | M | A | 12,723 | $0.79 | 25,723 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-04 | S | D | 31,000 | $5.00 | 13,000 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-03 | S | D | 26,000 | $4.69 | 44,000 | D | — | — | |
| 4 | Common | Common Stock | 2025-06-16 | M | A | 30,000 | $0.71 | 55,723 | D | — | — | |
| 5 | Common | Common Stock | 2025-06-16 | M | A | 52,500 | $1.10 | 108,223 | D | — | — | |
| 6 | Common | Common Stock | 2025-06-18 | S | D | 13,000 | $5.03 | 95,223 | D | — | — | |
| 7 | Common | Common Stock | 2025-06-23 | S | D | 31,800 | $6.36 | 63,423 | D | — | — | |
| 8 | Common | Common Stock | 2025-06-24 | S | D | 900 | $6.86 | 62,523 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-06-16 | M | D | 30,000 | $0.71 | 100,000 | D | $0.71 · — to 2030-07-09 | 30,000 Common Stock | (F3) 100,000 shares of the 200,000 option shares granted pursuant to Stock Option Agreement dated 7/9/2020 vested on 6/30/2022 upon achievement of Adjusted EBITDA performance milestone. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-06-16 | M | D | 12,723 | $0.79 | 0 | D | $0.79 · 2016-05-12 to 2026-05-12 | 12,723 Common Stock | |
| 11 | Derivative | Stock Option (Right to Buy) | 2025-06-16 | M | D | 52,500 | $1.10 | 0 | D | $1.10 · 2023-01-21 to 2032-01-21 | 52,500 Common Stock |